These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29967493)

  • 1. Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs.
    Vogel P; Moschref M; Li Q; Merkle T; Selvasaravanan KD; Li JB; Stafforst T
    Nat Methods; 2018 Jul; 15(7):535-538. PubMed ID: 29967493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for recruiting endogenous and exogenous ADAR enzymes for site-specific RNA editing.
    Xiang Y; Katrekar D; Mali P
    Methods; 2022 Sep; 205():158-166. PubMed ID: 35779766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAR regulates RNA editing, transcript stability, and gene expression.
    Wang IX; So E; Devlin JL; Zhao Y; Wu M; Cheung VG
    Cell Rep; 2013 Nov; 5(3):849-60. PubMed ID: 24183664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered alterations in RNA editing modulate complex behavior in Drosophila: regulatory diversity of adenosine deaminase acting on RNA (ADAR) targets.
    Jepson JEC; Savva YA; Yokose C; Sugden AU; Sahin A; Reenan RA
    J Biol Chem; 2011 Mar; 286(10):8325-8337. PubMed ID: 21078670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine Deaminases That Act on RNA (ADARs).
    Wang Y; Zheng Y; Beal PA
    Enzymes; 2017; 41():215-268. PubMed ID: 28601223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current strategies for Site-Directed RNA Editing using ADARs.
    Montiel-Gonzalez MF; Diaz Quiroz JF; Rosenthal JJC
    Methods; 2019 Mar; 156():16-24. PubMed ID: 30502398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
    Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
    RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
    Wang C; Zou J; Ma X; Wang E; Peng G
    Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An I for an A: Dynamic Regulation of Adenosine Deamination-Mediated RNA Editing.
    Vesely C; Jantsch MF
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1.
    Ko NL; Birlouez E; Wain-Hobson S; Mahieux R; Vartanian JP
    J Gen Virol; 2012 Dec; 93(Pt 12):2646-2651. PubMed ID: 22993189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.
    Yang W; Chendrimada TP; Wang Q; Higuchi M; Seeburg PH; Shiekhattar R; Nishikura K
    Nat Struct Mol Biol; 2006 Jan; 13(1):13-21. PubMed ID: 16369484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
    Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
    Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA binding-independent dimerization of adenosine deaminases acting on RNA and dominant negative effects of nonfunctional subunits on dimer functions.
    Valente L; Nishikura K
    J Biol Chem; 2007 Jun; 282(22):16054-61. PubMed ID: 17428802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing self-labeling enzymes for selective and concurrent A-to-I and C-to-U RNA base editing.
    Stroppel AS; Latifi N; Hanswillemenke A; Tasakis RN; Papavasiliou FN; Stafforst T
    Nucleic Acids Res; 2021 Sep; 49(16):e95. PubMed ID: 34197596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADARs, RNA editing and more in hematological malignancies.
    Teoh PJ; Koh MY; Chng WJ
    Leukemia; 2021 Feb; 35(2):346-359. PubMed ID: 33139858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do ADARs bind RNA? New protein-RNA structures illuminate substrate recognition by the RNA editing ADARs.
    Thomas JM; Beal PA
    Bioessays; 2017 Apr; 39(4):. PubMed ID: 28217931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA editing by mammalian ADARs.
    Hogg M; Paro S; Keegan LP; O'Connell MA
    Adv Genet; 2011; 73():87-120. PubMed ID: 21310295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAR1 and ADAR2 expression and editing activity during forebrain development.
    Jacobs MM; Fogg RL; Emeson RB; Stanwood GD
    Dev Neurosci; 2009; 31(3):223-37. PubMed ID: 19325227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins.
    Mannion N; Arieti F; Gallo A; Keegan LP; O'Connell MA
    Biomolecules; 2015 Sep; 5(4):2338-62. PubMed ID: 26437436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editing independent effects of ADARs on the miRNA/siRNA pathways.
    Heale BS; Keegan LP; McGurk L; Michlewski G; Brindle J; Stanton CM; Caceres JF; O'Connell MA
    EMBO J; 2009 Oct; 28(20):3145-56. PubMed ID: 19713932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.